FDA Warnings on Unapproved Weight Loss Drugs: How to Verify Your GLP-1 Medication

In the booming market for weight-loss medications, the U.S. Food and Drug Administration (FDA) has issued strong warnings about the dangers of unapproved GLP-1 drugs. Popular medications like Ozempic®, Wegovy®, Mounjaro®, and Zepbound® have become targets for counterfeiters and unethical compounders.

This article explains the FDA's specific concerns and provides clear, actionable steps to ensure the medication you are using is safe and approved.

Key Takeaways

• The FDA warns that unapproved GLP-1 drugs bypass rigorous safety reviews and have been linked to hospitalizations and adverse events.
• Counterfeit versions may contain incorrect ingredients, wrong dosages, or harmful substances, posing serious health risks.
• Compounded semaglutide and tirzepatide are no longer permitted under FDA rules due to the resolution of drug shortages.
• You can verify an FDA-approved drug by getting a valid prescription and having it filled at a state-licensed pharmacy.
• Never purchase these medications from online sources that do not require a prescription, as they are likely illegal and unsafe.

Why is the FDA warning about unapproved GLP-1 drugs for weight loss?

The FDA is issuing warnings because unapproved versions of GLP-1 drugs are flooding the market, and they have not been evaluated for safety, effectiveness, or quality . The high demand for these medications has created an opportunity for illegal and dangerous products to proliferate.

The agency has observed a rise in three main types of problematic products:

1. Counterfeit drugs: These are fake products designed to look identical to FDA-approved medicines. Hundreds of counterfeit Ozempic units have been found in the U.S. drug supply chain . These fakes may contain no medicine, the wrong ingredient, incorrect dosages, or even harmful substances .
2. Unsafe compounded drugs: Compounding is the process of combining or altering ingredients to create a medication tailored to an individual patient's needs. While compounding has a legal place for when an FDA-approved drug is not available, it does not undergo the FDA's pre-market review . The FDA has received over 1,150 reports of adverse events linked to compounded versions of semaglutide and tirzepatide .
3. Illegally marketed products: The agency has also cracked down on companies illegally selling unapproved drugs, including those falsely labeled "for research purposes" or "not for human consumption," which are then sold directly to consumers with dosing instructions .

The core of the FDA's concern is that patients using these unapproved products are taking unknown risks with their health.

How can I tell if my Ozempic or semaglutide is FDA-approved?

Verifying that your GLP-1 medication is genuine and FDA-approved requires careful attention to detail. Here is a checklist to help you confirm the authenticity of your medication.

• Get a valid prescription from your doctor. You should never be able to purchase these medications without a prescription from a licensed healthcare provider .
• Fill your prescription at a state-licensed pharmacy. This is your best defense against receiving a counterfeit or unapproved product .
• Carefully inspect the product packaging and labeling. Look for any signs of counterfeiting, such as spelling errors, non-English text, or incorrect information about the manufacturer .

Table: How to Spot a Fake or Unapproved Product

If you suspect you have a counterfeit product, the FDA recommends not using it. You can report it to the FDA by calling their consumer complaint coordinator or through their "Report Suspected Criminal Activity" database .

What risks come with using black market or fake GLP-1 injections?

Using black market or fake GLP-1 injections exposes you to severe and potentially life-threatening health risks. Unlike FDA-approved medicines, these products are manufactured without quality controls.

The specific dangers include:

• Unknown Ingredients: Fake injections may contain no active ingredient, the wrong medicine, incorrect dosages, or multiple drugs mixed together. In one instance, a product sold as tirzepatide was found to be nothing but sugar alcohol . Eli Lilly also reported finding a counterfeit Mounjaro pen that contained an entirely different type 2 diabetes medication that does not cause weight loss .
• Sterility Issues: Counterfeit products often have unsterile needles or are produced in non-sterile conditions. This can lead to serious infections . The sterility of these products cannot be confirmed, presenting a major risk to patients .
• Harmful Substances: These products could contain impurities, bacteria, or other harmful contaminants. Lilly has tested some compounded products and found they contained bacteria or had high impurity levels .
• Inconsistent Effects: Because the dosage and ingredients are unreliable, you might experience no effect, unexpected side effects, or a dangerous overdose.

Are compounded GLP-1 medications like semaglutide safe to use?

The safety of compounded GLP-1 medications cannot be guaranteed because they are not FDA-approved. The FDA states that "compounded drugs pose a higher risk to patients than FDA-approved drugs" .

Compounded drugs are intended for specific patient needs, such as when there is a shortage of an FDA-approved drug or if a patient is allergic to an ingredient in the commercial product. However, the legal landscape for compounding GLP-1 drugs has recently changed. The FDA has determined that the shortages for semaglutide and tirzepatide injection products have been resolved . This means the enforcement discretion that allowed widespread compounding of these drugs has ended. All compounded semaglutide and tirzepatide should no longer be available .

Even when compounding was more permissible, the FDA identified several specific safety concerns:

• Dosing Errors: The FDA received multiple reports of adverse events, some requiring hospitalization, due to patients or healthcare professionals miscalculating doses of compounded semaglutide from vials . FDA-approved pens are designed to deliver precise doses and eliminate this risk.
• Use of Unapproved Ingredients: Some compounders have used salt forms of semaglutide, like semaglutide sodium and semaglutide acetate. The FDA does not have information on whether these salts are safe and effective .
• Improper Storage: Injectable GLP-1 drugs require refrigeration. The FDA has received complaints that compounded drugs arrived warm or without adequate ice packs, which can affect the drug's quality and effectiveness .

What are the FDA's main concerns about unregulated weight loss drugs?

The FDA's concerns about unregulated weight loss drugs are comprehensive, focusing on every step from manufacturing to patient use.

Their primary worries include:

1. Lack of Quality Control: Unapproved drugs are made without complying with the FDA's rigorous Good Manufacturing Practice regulations. This can lead to inconsistent strength, contamination, and impurities .
2. Patient Dosing Dangers: As noted with compounded products, the potential for dosing errors is significant. This can lead to severe side effects or a lack of efficacy .
3. Fraudulent and Fake Pharmacies: The FDA is aware of compounded products with labels that list pharmacy names that do not exist. In other cases, the labeled pharmacy did not actually compound the product, meaning the source is completely unknown .
4. Illegal Ingredients: The agency has explicitly stated that certain substances, like retatrutide and cagrilintide, cannot be used in compounding. Retatrutide is still in clinical trials and is not a component of any FDA-approved drug, yet it is already being sold online illegally .
5. Unreliable Supply Chain: When you buy from an unlicensed source, you have no way of knowing how the drug was stored or handled during shipping. Breaks in the cold chain can render the medication ineffective or unsafe .

How can I verify my compounding pharmacy meets FDA safety standards?

With the recent policy changes, patients should be transitioning from compounded GLP-1 drugs to FDA-approved products. However, if you are considering a compounded medication for another need, here is how to approach it safely.

A key federal law restricts compounded drugs from being "essentially a copy" of an FDA-approved drug that is commercially available . Since the FDA has declared the shortages of key GLP-1 drugs resolved, compounding them is no longer permitted under the agency's enforcement discretion .

For other medications, you can take these steps to verify a compounding pharmacy:

• Ask if it is necessary. Remember, compounded drugs should only be used if your medical need cannot be met by an FDA-approved drug .
• Confirm the pharmacy is licensed. You can verify that a pharmacy is licensed through your state's Board of Pharmacy.
• Ask if the pharmacy is an "outsourcing facility." Outsourcing facilities (regulated under section 503B of the FD&C Act) are registered with the FDA and are subject to higher levels of federal oversight .
• Be wary of false claims. No compounded drug is FDA-approved. If a pharmacy claims its compounded product is "generic" Ozempic or the "same as" Mounjaro, this is false and misleading . Only products approved by the FDA can make such claims.

What to do if you suspect an adverse event

Your vigilance can help protect others. If you experience a side effect or suspect you have received a counterfeit or unsafe compounded drug, it is crucial to take action.

1. Stop using the product immediately.
2. Contact your healthcare provider. Discuss your symptoms and seek medical attention if needed.
3. Report the issue to the FDA. You can file a report through the FDA's MedWatch Adverse Event Reporting program online or by fax . This helps the agency identify and act against dangerous products more quickly.